Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Delta Manufacturing Q4 FY26 Results: Net Loss of ₹2.6 Cr, Loss Widens

Delta Manufacturing Ltd reported revenue from operations of ₹18.5 Cr (+18.6% YoY) and a net loss of ₹2.6 Cr for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations18.515.515.6
Other income1.30.10.1
Total income19.815.615.7
Profit before exceptional items & tax1.8-0.01.3
Exceptional items0.00.00.1
Profit before tax0.9-0.91.2
Net profit-2.6-5.2-0.4
Operating margin4.5%-5.8%7.6%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Revenue, year on year+18.60%
Source

BSE results filing, NSE: DELTAMAGNT. Figures extracted from the filing.

Read the filing ↗

Delta Manufacturing Ltd: key numbers

Share price
₹57.16
Market cap
₹62.02 Cr
Revenue (annual)
₹61.87 Cr
Net profit (annual)
₹-12.41 Cr
P/E (TTM)
-5.9×Sector 53.6×
Promoter holding
72.12%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Delta Manufacturing Ltd

All →
15:01 IST BSE
Other Announcement

Delta Manufacturing Other Announcement

Delta Manufacturing sent a Reg 36(1)(b) letter with the Annual Report 2025-26 web-link to shareholders without registered email addresses. No transaction or business event is disclosed.

14:51 IST BSE
Annual Report

Delta Manufacturing Annual Report

Delta Manufacturing Ltd filed its 44th Annual Report for FY 2025-26 under Regulation 34. The submission includes financial statements and the AGM notice for the year.

14:40 IST BSE
Annual General Meeting

Delta Manufacturing Annual General Meeting

Delta Manufacturing Ltd issued a notice for its 44th AGM on 30 September 2026 via VC/OAVM. The agenda covers related party transaction approvals and MD remuneration revision.